CompletedNCT05428033
Centanafadine safety and effects in children with ADHD
About this title
Read the official source —This study evaluated the safety and effectiveness of centanafadine capsule for people with ADHD.
Medication studyAges 4–12United States
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of centanafadine capsule for people with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: 4 years to 12 years. Other eligibility criteria applied.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: July 11, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 574
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 4 Years to 12 Years
- Official registry ID
- NCT05428033
- Official title
Show the full official title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Efficacy and Safety of Once Daily Centanafadine Capsules for the Treatment of Children With Attention-deficit/Hyperactivity Disorder (ADHD)
Get this study by email
Recruitment & locations
CompletedNew York
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of centanafadine capsule for people with ADHD.
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including centanafadine capsule.
Who was this study for?
This study was for people with ADHD. Listed age limits: 4 years to 12 years. Other eligibility criteria applied.
